Literature DB >> 10833306

Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures.

C M Vos1, L Sjulson, A Nath, J C McArthur, C A Pardo, J Rothstein, K Conant.   

Abstract

Extracellular matrix (ECM) proteins, including collagens and laminins, are critical to the structure of the neuronal synapse and may also be involved in cell survival. In the present study, we therefore examined the possibility that select ECM degrading proteins might be toxic to organotypic spinal cord and dissociated neuronal cultures. Of those proteins tested, including MMP-1, -7, and -9, we observed that MMP-1 was toxic to spinal cord cultures as determined by release of lactic acid dehydrogenase as well as uptake of propidium iodide. Pretreatment of cell cultures with 50 microM alpha-tocopherol partially reversed these effects. We also observed that MMP-1 was toxic to human neurons grown in dissociated cultures and that increased amounts of MMP-1 were released by astrocytes following their stimulation with IL-1beta. These results suggest that further studies may be warranted to determine whether MMP-1 contributes to neurodegenerative conditions in which activated astrocytes may play a role. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833306     DOI: 10.1006/exnr.2000.7388

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  24 in total

1.  Embryology and anatomy of the vesicoureteric junction with special reference to the etiology of vesicoureteral reflux.

Authors:  Christian Radmayr; Christian Schwentner; Andreas Lunacek; Anastasios Karatzas; Josef Oswald
Journal:  Ther Adv Urol       Date:  2009-12

2.  Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus.

Authors:  Arek Szklarczyk; Joanna Lapinska; Marcin Rylski; Ronald D G McKay; Leszek Kaczmarek
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 3.  Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.

Authors:  Ralf G Rempe; Anika M S Hartz; Björn Bauer
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-20       Impact factor: 6.200

4.  TSG-6 controls transcription and activation of matrix metalloproteinase 1 in conjunctivochalasis.

Authors:  Ping Guo; Su-Zhen Zhang; Hua He; Ying-Ting Zhu; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-15       Impact factor: 4.799

5.  Protection of human cerebral neurons from neurodegenerative insults by gene delivery of soluble tumor necrosis factor p75 receptor.

Authors:  Marc Adrian Williams; Jadwiga Turchan; Yang Lu; Avindra Nath; Daniel B Drachman
Journal:  Exp Brain Res       Date:  2005-04-13       Impact factor: 1.972

6.  Envelope gene-mediated neurovirulence in feline immunodeficiency virus infection: induction of matrix metalloproteinases and neuronal injury.

Authors:  J B Johnston; C Silva; C Power
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection.

Authors:  Ann B Ragin; Ying Wu; Renee Ochs; Rachel Scheidegger; Bruce A Cohen; Justin C McArthur; Leon G Epstein; Katherine Conant
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

Review 8.  Glial activation and matrix metalloproteinase release in cerebral malaria.

Authors:  A Szklarczyk; M Stins; E A Milward; H Ryu; C Fitzsimmons; D Sullivan; K Conant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

Review 9.  The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.

Authors:  Abbas Mirshafiey; Babak Asghari; Ghasem Ghalamfarsa; Farhad Jadidi-Niaragh; Gholamreza Azizi
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

10.  MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function.

Authors:  Arek Szklarczyk; Osefame Ewaleifoh; Jean-Claude Beique; Yue Wang; David Knorr; Norman Haughey; Tanya Malpica; Mark P Mattson; Richard Huganir; Katherine Conant
Journal:  FASEB J       Date:  2008-07-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.